351 related articles for article (PubMed ID: 19934000)
1. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
2. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
[TBL] [Abstract][Full Text] [Related]
3. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
[TBL] [Abstract][Full Text] [Related]
4. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.
Heni M; Ketterer C; Thamer C; Herzberg-Schäfer SA; Guthoff M; Stefan N; Machicao F; Staiger H; Fritsche A; Häring HU
Diabetes; 2010 Dec; 59(12):3247-52. PubMed ID: 20802253
[TBL] [Abstract][Full Text] [Related]
5. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.
Grespan E; Giorgino T; Natali A; Ferrannini E; Mari A
Metabolism; 2021 Jan; 114():154415. PubMed ID: 33137379
[TBL] [Abstract][Full Text] [Related]
7. Comment on: Villareal et al. (2009) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes;59:479-485.
Knop FK
Diabetes; 2010 Jun; 59(6):e4; author reply e5-6. PubMed ID: 20508220
[No Abstract] [Full Text] [Related]
8. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
9. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; Dekker JM; 't Hart LM; Nijpels G; van Haeften TW; Häring HU; Fritsche A
Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
[TBL] [Abstract][Full Text] [Related]
10. The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.
Alibegovic AC; Sonne MP; Højbjerre L; Hansen T; Pedersen O; van Hall G; Holst JJ; Stallknecht B; Dela F; Vaag A
Diabetes; 2010 Apr; 59(4):836-43. PubMed ID: 20107109
[TBL] [Abstract][Full Text] [Related]
11. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ
Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
[TBL] [Abstract][Full Text] [Related]
12. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
[TBL] [Abstract][Full Text] [Related]
13. No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect.
Mathiesen DS; Bagger JI; Hansen KB; Junker AE; Plamboeck A; Harring S; Idorn T; Hornum M; Holst JJ; Jonsson AE; Hansen T; Vilsbøll T; Lund A; Knop FK
Endocr Connect; 2020 Dec; 9(12):1221-1232. PubMed ID: 33252353
[TBL] [Abstract][Full Text] [Related]
14. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
15. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
[TBL] [Abstract][Full Text] [Related]
16. Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant.
Daniele G; Gaggini M; Comassi M; Bianchi C; Basta G; Dardano A; Miccoli R; Mari A; Gastaldelli A; Del Prato S
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1160-7. PubMed ID: 26046964
[TBL] [Abstract][Full Text] [Related]
17. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
Oh TJ; Kim MY; Shin JY; Lee JC; Kim S; Park KS; Cho YM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):221-7. PubMed ID: 23405851
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose cotransporter-2 inhibition improves incretin sensitivity of pancreatic β-cells in people with type 2 diabetes.
Ahn CH; Oh TJ; Kwak SH; Cho YM
Diabetes Obes Metab; 2018 Feb; 20(2):370-377. PubMed ID: 28786557
[TBL] [Abstract][Full Text] [Related]
19. Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?
Michaliszyn SF; Lee S; Bacha F; Tfayli H; Farchoukh L; Mari A; Ferrannini E; Arslanian S
Pediatr Diabetes; 2017 Mar; 18(2):143-151. PubMed ID: 26799689
[TBL] [Abstract][Full Text] [Related]
20. The incretin effect in critically ill patients: a case-control study.
Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
